A roadmap for supporting the development of advanced therapy medicinal products in a European framework
Open Access
- 4 May 2026
- journal article
- review article
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 66, 101688
Abstract
No abstract availableKeywords
Funding Information
- European Commission
- HORIZON EUROPE Framework Programme (101137206)
This publication has 11 references indexed in Scilit:
- Strategic recommendations from the STARS project to foster academic drug developmentNature Reviews Drug Discovery, 2023
- Place of care manufacturing of chimeric antigen receptor cells: Opportunities and challengesSeminars in Hematology, 2023
- Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in EuropeClinical Pharmacology & Therapeutics, 2022
- Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutionsDrug Discovery Today, 2021
- Advanced Therapy Medicinal Products Challenges and Perspectives in Regenerative MedicineJournal of Clinical Medicine Research, 2020
- Regulatory considerations for decentralized manufacture of ATMPsCell & Gene Therapy Insights, 2019
- Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and managementBlood Reviews, 2019
- Preclinical Development of Cell-Based Products: a European Regulatory Science PerspectivePharmaceutical Research, 2018
- Toxicology and Biodistribution: The Clinical Value of Animal Biodistribution StudiesMolecular Therapy - Methods & Clinical Development, 2018
- Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk AssessmentCell Stem Cell, 2017